Henry Morgan is Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC). They have made 8 open-market trades across 1 company since 2009, most recently 2014-06-06.
CIK 0001375327
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSTC | 32,193 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2014-06-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BSTC | SELL | 2014-06-03 | 2014-06-05 | $27.00 | $484K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2014-05-30 | 2014-06-03 | $27.01 | $56K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2014-05-28 | 2014-05-30 | $27.04 | $541K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2014-05-19 | 2014-05-21 | $25.84 | $517K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2013-09-04 | 2013-09-06 | $18.48 | $330K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2013-08-30 | 2013-09-04 | $18.34 | $39K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2009-12-15 | 2009-12-17 | $30.31 | $9K | -9.3% | -6.3% | -6.3% |
| BSTC | SELL | 2009-12-11 | 2009-12-15 | $30.05 | $344K | -9.3% | -6.3% | -6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.